Plasma membrane NADH-oxidoreductase in cells carrying mitochondrial DNA G11778A mutation and in cells devoid of mitochondrial DNA (ρ0)

BioFactors

Volumn 20, Issue 4, 2004, Pages 189-198

  Malik, Safarina G ^a,b   Vaillant, François ^a,c   Lawen, Alfons ^a  

^a MONASH UNIVERSITY   (Australia)

^b EIJKMAN INSTITUTE FOR MOLECULAR BIOLOGY   (Indonesia)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

LHON; mtDNA; NADH ferricyanide reductase; NADH oxidase; Plasma membrane; PMOR; 0 cells

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOCHROME B5 REDUCTASE; MITOCHONDRIAL DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE;

ANAEROBIC GLYCOLYSIS; CELL COMPOSITION; CELL GROWTH; CELL MEMBRANE; CELL STRAIN HL 60; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; FIBROBLAST; HELA CELL; HUMAN; HUMAN CELL; MUTATION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; SHORT SURVEY; UPREGULATION;

EID: 13444257500     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520200402     Document Type: Short Survey

References (43)

1. M.A. Baker and A. Lawen, Plasma membrane NADH-oxidoreductase system: a critical review of the structural and functional data, Antioxid. Redox Signal 2 (2000), 197-212.
2. M.A. Baker, D.J. Lane, J.D. Ly, V. De Pinto and A. Lawen, VDAC1 Is a transplasma membrane NADH-ferricyanide reductase, J. Biol. Chem 279 (2004), 4811-4819.
3. M.A. Baker, J.D. Ly and A. Lawen, Characterization of VDAC1 as a plasma membrane NADH-oxidoreductase, BioFactors (2004), in press.
4. M.V. Berridge and A.S. Tan, Trans-plasma membrane electron transport: a cellular assay for NADH- and NADPH-oxidase based on extracelullar, superoxide-mediated reduction of the sulfonated tetrazolium salt WST-1, Protoplasma 205 (1998), 74-82.
5. A.O. Brightman, J. Wang, R.K.-M. Miu, I.L. Sun, R. Barr, F.L. Crane and D.J. Morré, A growth factor- and hormone-stimulated NADH oxidase from rat liver plasma membrane, Biochim. Biophys. Acta 1105 (1992), 109-117.
6. L.R. Cavalli and B.C. Liang, Mutagenesis, tumorigenicity, and apoptosis: are the mitochondrial involved? Mutat. Res. 398 (1998), 19-26.
7. M.G. Clark, E.J. Patrick, G.S. Patten, F.L. Crane, H. Löw and C. Grebing, Evidence for the extracellular reduction of ferricyanide by rat liver. A trans-plasma membrane redox system, Biochem. J. 200 (1981), 565-572.
8. F.L. Crane, I.L. Sun, M.G. Clark, C. Grebing and H. Löw, Transplasma-membrane redox systems in growth and development, Biochim, Biophys, Acta 811 (1985), 233-264.
9. M. Degli Esposti, V. Carelli, A. Ghelli, M. Ratta, M. Crimi, S. Sangiorgi, P. Montagna, G. Lenaz, E. Lugaresi and P. Cortelli, Functional alterations of the mitochondrially encoded ND4 subunit associated with Leber's hereditary optic neuropathy, FEBS Lett. 352 (1994), 375-379.
10. 2+ as second messengers, J. Bioenerg. Biomembr. 27 (1995), 605-611.
11. A. del Castillo-Olivares, A. Esteban del Valle, J. Márquez, I. Núñez de Castro and M.A. Medina, Effects of protein kinase C and phosphoprotein phosphatase modulators on Erlich cell plasma membrane redox system activity, Biochim. Biophys. Acta 1313 (1996), 157-160.
12. H. Goldenberg, F.L. Crane and D.J. Morrá, NADH oxidoreductase of mouse liver plasma membranes, J. Biol. Chem. 254 (1979), 2491-2498.
13. M. Grégoire, R. Morais, M.A. Quilliam and D. Gravel, On auxotrophy for pyrimidines of respiration-deficient chick embryo cells, Eur. J. Biochem. 142 (1984), 49-55.
14. S.G. Golshani-Hebroni and S.P. Bessman, Hexokinase binding to mitochondria: a basis for proliferative energy metabolism, J. Bioenerg. Biomembr. 29 (1997), 331-338.
15. P.M. Herst, A.S. Tan, D.-J.G. Scarlett and M.V. Berridge, Cell surface oxygen consumption by mitochondrial gene knockout cells, Biochim. Biophys. Acta 1656 (2004), 79-87.
16. G. Hofhaus, D.R. Johns, O. Hurko, G. Attardi and A. Chomyn, Respiration and growth defects in transmitochondrial cell lines carrying the 11778 mutation associated with Leber's hereditary optic neuropathy, J. Biol. Chem. 271 (1996), 13155-13161.
17. M. Kalbáčová, M. Vrbacký, Z. Drahota and Z. Mělková, Comparison of the effect of mitochondrial inhibitors on mitochondrial membrane potential in two different cell lines using flow cytometry and spectrofluorometry, Cytometry 52A (2003), 110-116.
18. M.P. King and G. Attardi, Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation, Science 246 (1989), 500-503.
19. 0 cells, J. Biol. Chem. 269 (1994), 30097-30100.
20. A. Lawen, R.D. Martinus, G.L. McMullen, P. Nagley, F. Vaillant, E.J. Wolvetang and A.W. Linnane, The universality of bioenergetic disease: the role of mitochondrial mutation and the putative interrelationship between mitochondria and plasma membrane NADH oxidoreductase, Mol. Aspects Med. 15(Suppl) (1994), s13-s27.
21. A. Lawen, M.A. Baker and S. Malik, Apoptosis and redox homeostasis: on a possible mechanism of action of Bcl-2, Protoplasma 205 (1998), 1-4.
22. J.D. Ly and A. Lawen, Transplasma membrane electron transport: enzymes involved and biological function, Redox Rep. 8 (2003), 3-21.
23. A. Majander, K. Huoponen, M.L. Savountos, E. Nikoskelainen and M. Wikstrom, Electron transfer properties of NADH:ubiquinone reductase in the ND1/3460 and the ND4/11778 mutations of the Leber hereditary optic neuropathy, FEBS Lett. 292 (1991), 289-292.
24. S. Malik, H. Sudoyo and S. Marzuki, Microphotometric analysis of NADH-tetrazolium reductase deficiency in fibroblasts of patients with Leber hereditary optic neuropathy, J. Inherit. Metab. Dis. 23 (2000), 730-744.
25. S. Marzuki, A.S. Noer, P. Lertrit, P. Utthanaphol, D. Thyagarajan, R. Kapsa, H. Sudoyo and E. Byrne, Molecular pathology of mitochondrial respiratory disorders: normal nucleotide variants of human mitochondrial genome and mtDNA lesion in MERRF encephalomyopathy, in: Progress in neuropathology, (Vol. 7), T. Sato and S. DiMauro, eds, Raven, New York, 1991, pp. 181-193.
26. S.P. Mathupala, A. Rempel and P.L. Pedersen, Aberrant glycolytic metabolism of cancer cells: a remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for type II hexokinase, J. Bioenerg. Biomembr. 29 (1997), 339-343.
27. M.Á. Medina, A. del Castillo-Olivares and I. Núñez de Castro, Multifunctional plasma membrane redox systems, Bioessays 19 (1997), 977-984.
28. D.J. Morré and A.O. Brightman, NADH oxidase of plasma membranes, J. Bioenerg. Biomembr. 23 (1991), 469-489.
29. D.J. Morré, P.-J. Chueh and M.M. Morré, Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture, Proc. Natl. Acad. Sci. USA 92 (1995), 1831-1835.
30. P.R. Smith, J.M. Cooper, G.G. Govan, A.E. Harding and A.H. Schapira, Platelet mitochondrial function in Leber's hereditary optic neuropathy, J Neurol Sci 122 (1994), 80-83.
31. H. Sudoyo, S. Marzuki, F. Mastaglia and W. Carroll, Molecular genetics of Leber's hereditary optic neuropathy: Study of a six-generation family from Western Australia, J. Neurol. Sci. 108 (1995), 7-17.
32. H. Sudoyo, M. Sitepu, S. Malik, H.D. Poesponegoro and S. Marzuki, Leber's hereditary optic neuropathy in Indonesia: Two families with the mtDNA 11778G>A and 14484T>C mutations, Hum. Mutat. (Suppl 1) (1998), S271-S274.
33. I.L. Sun, F.L. Crane, C. Grebing and H. Löw, Transmembrane redox in control of cell growth. Stimulation of HeLa cell growth by ferricyanide and insulin, Exp. Cell. Res. 156 (1985), 528-536.
34. I.L. Sun, F.L. Crane, D.J. Morré and W.P. Faulk, Inhibition of transplasma membrane electron transport by transferrin-adriamycin conjugates, Biochim. Biophys. Acta 1105 (1992), 34-38.
35. I.L. Sun, E.E. Sun, F.L. Crane, D.J. Morré, A. Lindgren and H. Löw, Requirement for coenzyme Q in plasma membrane electron transport, Proc. Natl. Acad. Sci. USA 89 (1992), 11126-11130.
36. I.L. Sun, F.L. Crane and H. Löw, Bombesin stimulates transplasma-membrane electron transport in Swiss 3T3 cells, Biochim. Biophys. Acta 1221 (1994), 206-210.
37. 0), 5th International Conference on Plasma Membrane Redox Systems and their Role in Biological Stress and Disease, Hamburg, Germany; March 26-29, 2000, p. 14.
38. F. Vaillant, B.E. Loveland, P. Nagley and A.W. Linnane, Some biochemical properties of human lymphoblastoid Namalwa cells grown anaerobically, Biochem. Int. 23 (1991), 571-580.
39. d), Hum. Mol. Genet. 4 (1995), 903-914.
40. F. Vaillant, J.A. Larm, G.L. McMullen, E.J. Wolvetang and A. Lawen, Effecters of the mammalian plasma membrane NADH-oxidoreductase system. Short-chain ubiquinone analogues as potent stimulators, J. Bioenerg. Biomembr. 28 (1996), 531-540.
41. M.M. Van Duijn, J. Van der Zee, J. VanSteveninck and P.J.A. Van den Broek, Ascorbate stimulates ferricyanide reduction in HL-60 cells through a mechanism distinct from the NADH-dependent plasma membrane reductase, J. Biol. Chem. 273 (1998), 13415-13420.
42. D.C. Wallace, G. Singh, M.T. Lott, J.A. Hodge, T.G. Schurr, A.M. Lezza, L.J. Elsas and E.K. Nikoskelainen, Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy, Science 242 (1988), 1427-1430.
43. E.J. Wolvetang, J.A. Larm, P. Moutsoulas and A. Lawen, Apoptosis induced by inhibitors of the plasma membrane NADH-oxidase involves Bcl-2 and calcineurin, Cell Growth Differ. 7 (1996), 1315-1325.